| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | TL-1-85 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.1 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | ZSTK474 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.077 | 0.1 |